Navigation Links
Researchers identify mechanism that makes breast cancer invasive
Date:3/29/2012

A new study has identified a key mechanism that causes breast cancer to spread. The research, published by Cell Press on March 30th in the journal Molecular Cell, enhances our knowledge about the signals that drive cancer metastasis and identifies new therapeutic targets for a lethal form of invasive breast cancer that is notoriously resistant to treatment.

Amplification of the gene for ErbB2 has been linked with aggressive forms of breast cancer and is associated with a poor outcome. Although ErbB2-positive breast cancers are routinely treated with chemotherapy and the ErbB2-targeted drug trastuzumab (Herceptin), this treatment often fails. "Nearly half of breast cancers with high ErbB2 expression are either initially non-responsive or eventually develop resistance to trastuzumab," explains senior study author, Dr. Tuula Kallunki, from the Danish Cancer Society Research Center. "Therefore, a better understanding of the molecular basis of ErbB2-induced malignancy is critical for further development of targeted treatments."

In the current study, Dr. Kallunki and colleagues discovered that ErbB2 induces expression of proteins called cathepsins. Previous work has linked cathepsins with metastasis of pancreatic cancer, specifically with tumor cell invasion of surrounding tissues and with the establishment of tumor blood supply. Using a three-dimensional model system to study ErbB2-induced cellular invasion, the researchers demonstrated that inhibition of cathepsins prevented ErbB2-driven breast cancer invasion. They went on to identify components of the complex signaling network linking ErbB2 and cathepsin expression with cancer invasiveness.

Taken together, the results demonstrate that the invasive behavior of ErbB2-positive cancer cells is dependent on cathepsin activity and uncover a molecular link between ErbB2 and breast cancer invasion. "Our work has introduced a cellular model system to study ErbB2-induced invasion and identified an invasion-promoting signaling network," concludes Dr. Kallunki. "In addition, our findings provide several potential therapeutic targets against ErbB2-driven invasive cancers."


'/>"/>

Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. Penn researchers call for a re-examination of transplant waitlist prioritization
2. Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke
3. NIH researchers highlight progress, path forward for developing TB vaccines
4. Penn researchers find mentoring provides health benefits for African American veterans with diabetes
5. Mayo Clinic researchers building melanoma vaccine to combat skin cancer
6. Evidence builds that meditation strengthens the brain, UCLA researchers say
7. Wilmot researchers create new way to study liver cancer
8. Researchers develop first theranostic treatment for acute lymphoblastic leukemia (ALL)
9. Researchers find possible genetic keys to surviving epithelial ovarian cancer
10. Researchers discover possible approach to the treatment of aggressive breast cancer
11. Researchers ID gene behind primary cervical dystonia, a neck-twisting disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... PhD, announced at his Inauguration that WesternU will move forward in bold new ... compass. , WesternU combined Wilson’s Inauguration ceremony with Convocation, the traditional opening of ...
(Date:8/15/2017)... Philadelphia, PA (PRWEB) , ... August 15, 2017 , ... ... they have embarked on a new three-year partnership to expand the City’s commitment to ... AACR supports activities that encourage the public to lead a healthy lifestyle as research ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading dental marketing ... Fast 50 list of Fastest Growing Companies in Tampa Bay. The Tampa Bay Business ... shown three consecutive years of growth. For this year’s award, Progressive Dental ranked number ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Richard Amato is raising ... as a periodontist in Monroe, CT since 1989, Dr. Amato understands that ... is educating his community on how to choose the right clinician for their periodontal ...
(Date:8/15/2017)... Louis Park, Minnesota (PRWEB) , ... August 15, 2017 , ... ... the Hearing Loss Association of America’s HLAA Twin Cities Living Well with Hearing Loss ... Monterey Drive, St. Louis Park, Minnesota. Look for Harris Communications at tables 8 and ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/2/2017)... 2, 2017  Life Flight Network and PeaceHealth Oregon Network ... patient care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, ... and Life Flight Network work collaboratively to move patients who ... when a time sensitive emergency exists. ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: